Fully Funded PhD in Amorphous Form Development for Low Bioavailability Drug Candidates University of Strathclyde in United Kingdom

Fully funded PhD opportunity at the University of Strathclyde (CMAC), based at the Technology and Innovation Centre, Glasgow, in collaboration with industry partner GSK.

The project is titled “Accelerating & de-risking amorphous form development for low bioavailability drug candidates.” It focuses on pharmaceutical sciences, chemistry, and materials science, combining high-throughput automation with advanced characterisation to improve formulation development and move away from traditional trial-and-error approaches.

This is a 4-year fully funded PhD and is described as an industry demand-led project co-sponsored by GSK. The post does not specify stipend amount, tuition coverage details, or additional benefits.

Applicants should be motivated researchers with an interest in drug formulation, amorphous solid forms, and analytical/characterisation methods. No explicit degree classification, GPA, or language-test requirements are mentioned in the post.

Deadline: 31 July 2026.

How to apply: Read the full details using the provided link and follow the application instructions on the opportunity page. Prepare your application before the deadline and highlight relevant research experience or interest in formulation, automation, and characterisation.